You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 3, February 9, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Conflict of Interest
 •Complementary and Alternative Medicine
 •Osteoarthritis
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Structural and Symptomatic Efficacy of Glucosamine and Chondroitin: Relevant Financial Interest?—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

My colleagues and I read with the greatest attention the letter by Dr Jobanputra. Dr Jobanputra is correct in stating that some of the authors were involved in one of the key trials1 cited in our systematic review.2 However, some points that justify why we did not declare any conflict of interests relevant to this article should be clarified.

  • The Lancet study1 was completed in 1999, and no further support was obtained after that date from Rottapharm Research, the initial sponsor of the study. It is not a common practice to report, in scientific publications, research grants having been terminated more than 3 years before the publication of an article.
  • The Lancet study was contracted by the University of Liege, Liege, Belgium, and notwithstanding that the authors belong to this institution, none of them received any direct or indirect financial compensation for this work.
  • The meta-analysis published in . . . [Full Text of this Article]

Jean-Yves Reginster, MD, PhD
Liege, Belgium



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Structural and Symptomatic Efficacy of Glucosamine and Chondroitin: Relevant Financial Interest?
Paresh Jobanputra
Arch Intern Med. 2004;164(3):338-339.
EXTRACT | FULL TEXT  

Structural and Symptomatic Efficacy of Glucosamine and Chondroitin in Knee Osteoarthritis: A Comprehensive Meta-analysis
Florent Richy, Olivier Bruyere, Olivier Ethgen, Michel Cucherat, Yves Henrotin, and Jean-Yves Reginster
Arch Intern Med. 2003;163(13):1514-1522.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.